Clinical Efficacy Of The Combination Of Qinggan Mixture And Western Medicine In The Conventional Treatment Of Community-Acquired Pneumonia With Wind-Heat-Invading Lung Type

Objective:To observe the effects of an in-hospital preparation of "Qinggan Mixture" in combination with conventional Western medicine in the treatment of patients with community-acquired pneumonia(wind-heat type)on the Chinese medicine syndrome score,inflammation-related indexes and lung imaging.This trial was conducted to evaluate the clinical efficacy and safety of the treatment of community-acquired pneumonia(wind-heat-involved lung type)with the combination of Qingxiangxiangxiangxiangxiang.Methods: In this study,60 patients with community-acquired pneumonia attending the pulmonary department of Enshizhou Ethnic Hospital from January 2022 to October 2022 were selected and met the Western diagnostic criteria for community-acquired pneumonia and the TCM diagnostic criteria for community-acquired pneumonia with wind-heat-involved lung disease.The control group and the treatment group,each with 30 cases.Each group was given different treatment methods,with the treatment group being given Qinggan Mixture combined with conventional Western medicine(anti-infection + symptomatic support treatment)and the control group being given conventional Western medicine treatment.The treatment course for both groups was 7 days.The statistical software was SPSS26.0,which was used to process the data required for this trial,and different statistical methods were used to analyze the data according to the type of data,so as to evaluate the effectiveness of Qinggan Mixture medicine combined with western medicine conventional treatment(anti-infection + western medicine support).The clinical efficacy and safety of the combination of western medicine conventional treatment of community-acquired pneumonia with wind-heat offending lung.Results:1.Before treatment,there were no statistical differences(P>0.05)when comparing the age,gender,total TCM evidence score,TCM evidence score,laboratory indices(WBC,CRP,NE%,PCT),and lung CT of the two groups.60 patients with community-acquired pneumonia included in this trial successfully completed this trial without adverse events throughout.2.Both treatment modalities were The total effective rate of TCM symptoms in the treatment group and the control group were 96.7% and 83.3%,respectively;the total effective rate of Western medicine clinical in the treatment group and the control group were 96.7% and 86.7%,respectively,and the differences were statistically significant(P<0.05)when the total effective rate of TCM symptoms and the total effective rate of Western medicine clinical in the two groups were statistically analyzed.It means that the treatment group is significantly better than the control group.3.The treatment modality of the treatment group can significantly reduce the total TCM symptoms points of patients,and the total TCM symptoms points of the treatment group are significantly lower than those of the control group,and the difference is statistically significant(P<0.05).4.Intra-group comparison of TCM symptoms points: after treatment,the points of each symptom in both groups are reduced compared with those before,and the difference is statistically significant by statistical analysis;inter-group comparison : After treatment,the symptom scores of fever,dry throat and unpleasant coughing sputum in the treated group were significantly different from those in the control group(P<0.05),while the remaining symptoms were not statistically different between groups(P>0.05).5.Comparison of laboratory indexes: intra-group comparison: after treatment,the levels of WBC,NE%,CRP and PCT in both groups decreased compared with those before treatment,and the differences were statistically significant(P<0.05);inter-group comparison: After treatment,the levels of WBC,NE%,CRP and PCT in the two groups were significantly different,and the difference was statistically significant(P<0.05),indicating that the treatment group was superior to the control group.6.Lung CT: After treatment,the lung CT inflammation absorption of the two groups was compared,and the difference was not statistically significant by statistical analysis(P>0.05).7.Clear Sensory Combination Agent in this trial No adverse reactions occurred during this trial,and all safety indexes were within the normal range,and the efficacy was worth promoting and the safety was reliable.